{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:12:30Z","timestamp":1793967150074,"version":"4.8.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"40","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,22]]},"DOI":"10.1093\/eurheartj\/ehaf782","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:01:44Z","timestamp":1761091304000},"page":"3939-3943","source":"Crossref","is-referenced-by-count":5,"title":["Improving understanding and management of acute heart failure, myocarditis, pericarditis, amyloidosis, mitochondrial cardiomyopathies, hypertrophic cardiomyopathy, and takotsubo syndrome"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-411X","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Center of Excellence of Cardiovascular Sciences, Ospedale Isola Tiberina \u2013 Gemelli Isola , Rome ,","place":["Italy"]},{"name":"Catholic University of the Sacred Heart , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"2025102120013578900_ehaf782-B1","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1093\/eurheartj\/ehaf544","article-title":"A new journal for the cardiovascular community","volume":"46","author":"L\u00fcscher","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B2","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC Guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B3","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1093\/eurheartj\/ehae752","article-title":"Evolving therapeutic approaches to aortic stenosis, tricuspid regurgitation, hypertrophic cardiomyopathy, and acute heart failure","volume":"45","author":"Crea","year":"2024","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B4","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1093\/eurheartj\/ehae561","article-title":"In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trial","volume":"45","author":"Tanaka","year":"2024","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B5","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1093\/eurheartj\/ehad617","article-title":"Acute heart failure: current pharmacological treatment and perspectives","volume":"44","author":"Deniau","year":"2023","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B6","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1093\/eurheartj\/ehad560","article-title":"Acetazolamide for acute heart failure: is ADVOR a riddle wrapped in a mystery inside an enigma?","volume":"44","author":"Bueno","year":"2023","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B7","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1093\/eurheartj\/ehad463","article-title":"Prevention and treatment of diuretic resistance in acute heart failure: when to use which combination of diuretics?","volume":"44","author":"Martens","year":"2023","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B8","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/eurheartj\/ehad403","article-title":"Challenges and opportunities in the management of acute heart failure and cardiac amyloidosis","volume":"44","author":"Crea","year":"2023","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B9","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/eurheartj\/ehad335","article-title":"NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial","volume":"44","author":"Adamo","year":"2023","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B10","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1093\/eurheartj\/ehaf559","article-title":"Acute heart failure in non-cardiac surgery","volume":"46","author":"Gualandro","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/eurheartj\/ehae821","article-title":"Targeting mitochondrial fitness for cardioprotection","volume":"46","author":"Hernandez-Resendiz","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B12","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1093\/eurheartj\/ehad710","article-title":"Post-translational modifications upon mitochondrial dysfunction in heart failure","volume":"44","author":"Sluijter","year":"2023","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/eurheartj\/ehad028","article-title":"Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration","volume":"44","author":"Nollet","year":"2023","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B14","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1093\/eurheartj\/ehaf491","article-title":"Mitochondrial cardiomyopathies: pathogenesis, diagnosis, and treatment","volume":"46","author":"Maack","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/eurheartj\/ehae507","article-title":"Hypertrophic cardiomyopathy evolving management: American Heart Association\/American College of Cardiology vs. European Society of Cardiology guidelines","volume":"46","author":"Bertero","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B16","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1093\/eurheartj\/ehae710","article-title":"Advances in the treatment of hypertrophic cardiomyopathy","volume":"45","author":"Braunwald","year":"2024","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B17","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1093\/eurheartj\/ehae590","article-title":"Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial","volume":"45","author":"Coats","year":"2024","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B18","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1093\/eurheartj\/ehae579","article-title":"Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Garcia-Pavia","year":"2024","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B19","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1093\/eurheartj\/ehaf364","article-title":"Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUIOA-HCM Trial","volume":"46","author":"Maron","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B20","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1093\/eurheartj\/ehaf507","article-title":"Cardiac myosin inhibitors in hypertrophic cardiomyopathy: the need for precision medicine","volume":"46","author":"Yilmaz","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B21","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1093\/eurheartj\/ehaf387","article-title":"Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool","volume":"46","author":"Slivnick","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B22","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1093\/eurheartj\/ehaf388","article-title":"AI-based screening of cardiac amyloidosis on standard echocardiography: promising advances but need for real-world validation","volume":"46","author":"Aimo","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B23","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1093\/eurheartj\/ehaf324","article-title":"Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model","volume":"46","author":"Baka","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B24","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1093\/eurheartj\/ehaf395","article-title":"Empagliflozin to energize the heart of patients with hypertrophic cardiomyopathy","volume":"46","author":"van der Velden","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B25","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1093\/eurheartj\/ehaf392","article-title":"Pulmonary arterial wedge pressure exceeding left atrial pressure: clinical implications","volume":"46","author":"Tada","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B26","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1093\/eurheartj\/ehaf441","article-title":"Takotsubo syndrome: cognitive behavioural therapy, physical training, and brain function recovery in the BREAKOUT trial","volume":"46","author":"Khan","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B27","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1093\/eurheartj\/ehaf486","article-title":"Biomarkers predict cardiovascular outcomes in European cohort","volume":"46","author":"Xing","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B28","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1093\/eurheartj\/ehaf209","article-title":"Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study","volume":"46","author":"Kraaijenhof","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B29","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1093\/eurheartj\/ehae488","article-title":"Combining 4D flow magnetic resonance imaging with cardiac catheterization for pre-operative blood flow assessment in an older child with complex congenital heart disease","volume":"45","author":"Bai","year":"2024","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B30","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1093\/eurheartj\/ehaf482","article-title":"Nonagenarian patients with ATTR cardiac amyloidosis: should they be treated with tafamidis?","volume":"46","author":"Jobb\u00e9-Duval","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B31","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/eurheartj\/ehae923","article-title":"Tafamidis in octogenarians with wild-type transthyretin cardiac amyloidosis: an international cohort study","volume":"46","author":"Debonnaire","year":"2025","journal-title":"Eur Heart J"},{"key":"2025102120013578900_ehaf782-B32","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1093\/eurheartj\/ehaf484","article-title":"Tafamidis treatment in the very elderly: what matters most?","volume":"46","author":"Debonnaire","year":"2025","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/40\/3939\/64831271\/ehaf782.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/40\/3939\/64831271\/ehaf782.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:01:44Z","timestamp":1761091304000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/40\/3939\/8294310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":32,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2025,10,22]]},"published-print":{"date-parts":[[2025,10,22]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf782","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,21]]},"published":{"date-parts":[[2025,10,21]]}}}